País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
Aspirin
Bayer Limited
N02BA; N02BA01
Aspirin
300 milligram(s)
Effervescent tablet
Product not subject to medical prescription
Salicylic acid and derivatives; acetylsalicylic acid
Not marketed
1976-06-08
BCH20056 Package Leaflet: Information for the user ASPIRIN 300MG EFFERVESCENT TABLETS Acetylsalicylic acid (Aspirin) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if you feel worse after 3 days. WHAT IS IN THIS LEAFLET: 1. What Aspirin is and what it is used for 2. What you need to know before you take Aspirin 3. How to take Aspirin 4. Possible side effects 5. How to store Aspirin 6. Contents of the pack and other information 1. WHAT ASPIRIN IS AND WHAT IT IS USED FOR Each effervescent tablet contains aspirin (acetylsalicylic acid). They dissolve in water to form a sparkling, lemon-tasting solution which is absorbed quickly into the bloodstream. Aspirin belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDS). It is used for the treatment of pain and reduction of fever and also has anti- inflammatory properties. Aspirin can be used for the: Treatment of mild to moderate pain including headache, migraine, toothache, period pains, sore throat, nerve pain (neuralgia), aches and pains. Symptomatic relief of influenza, feverishness, colds, backache (lumbago), sciatica, fibrositis, rheumatic pain (arthritis), muscular aches and pains. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ASPIRIN DO NOT TAKE ASPIRIN IF YOU: Are allergic to aspirin or any of the other ingredients of this medicine_ (listed in section _ _6)_. Are allergic to any other pain relieving or anti-inflammatory medicines (e.g. NSAIDS or salicylates). _For more information see Section 4_, ‘_Possible Side Eff Leia o documento completo
Health Products Regulatory Authority 10 January 2024 CRN00DTQC Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aspirin 300mg Effervescent tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Acetylsalicylic Acid (aspirin) 300.00 mg. Excipients with known effect: Sodium 150 mg (6.5 mmol) per tablet. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Effervescent Tablet White, circular tablets, with a scoreline on one face (to allow breaking for ease of swallowing) and the other side plain. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The symptomatic relief of influenza, feverishness, feverish colds, and of lumbago, sciatica, fibrositis, rheumatic pains, muscular aches and pains. The relief of mild to moderate pain including headache, migraine, toothache, period pains, sore throat, neuralgia, aches and pains. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: 2 tablets in half a glass of water every 4 hours as required. Do not exceed 13 tablets in 24 hours unless directed by a doctor. Aspirin must not be taken for longer than 3-5 days without consulting your doctor. If symptoms persist consult your doctor. Medicines should not be taken in pregnancy without consulting your doctor. Elderly: As for adults. _Paediatric population_ Do not give to children and adolescents aged under 16 years, except on medical advice, where the benefit outweighs the risk. In case of accidental administration or use in children, see section "Special warning and precautions for use". Method of administration Oral. Tablets must be dissolved in water. The tablets should preferably be taken after meals. 4.3 CONTRAINDICATIONS Aspirin must not be used in the following cases: Health Products Regulatory Authority 10 January 2024 CRN00DTQC Page 2 of 9 hypersensitivity to acetylsalicylic acid or other salicylates, or to any of the excipients listed in section 6.1 a history of asthma induced by the administration of salicylates or substances with a similar a Leia o documento completo